SCHEMBL6140723

SCHEMBL6140723

COc1cc(N(C)Cc2ccccc2)ccc1C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
HPGD P15428 1/20 0.50
BCHE P06276 2/20 0.47
ACHE P22303 2/20 0.47
PARP15 Q460N3 2/20 0.46
SLC16A3 O15427 2/20 0.46
SLC16A1 P53985 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PARP1 P09874 1/20 0.45
TSHR P16473 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
PARP10 Q53GL7 1/20 0.44
RPS6KB1 P23443 1/20 0.44
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6141007 0.91 PARP1 (0.48) ACHEPARP15PARP1TSHRPARP10
SCHEMBL6141139 0.87 L3MBTL1 (0.46) GAAHPGDBCHEACHEPARP15
SCHEMBL6140972 0.83 PARP1 (0.46) PARP15MEN1KMT2APARP1PARP10
SCHEMBL12970697 0.78 LMNA (0.57) GAAHPGDPARP15MEN1KMT2A
SCHEMBL6111720 0.77 MCHR1 (0.64) ACHE
SCHEMBL10949296 0.77 SLC16A3 (0.57) GAAHPGDSLC16A3SLC16A1MEN1
SCHEMBL13177255 0.76 KDM4E (0.47) GAAMEN1KMT2ATSHRKDM4E
SCHEMBL11596722 0.76 ACHE (0.54) GAAHPGDBCHEACHEPARP15
SCHEMBL6141196 0.75 MAPT (0.53) GAAHPGDMEN1KMT2AKDM4E
SCHEMBL6155453 0.75 ACHE (0.50) GAAHPGDBCHEACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497260-A1 NOVEL METHOXYBENZAMIDE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS 7TM Pharma A/S (DK) 2005-01-19 EP disclosed
WO-2003087045-A1 NOVEL METHOXYBENZAMIDE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS 7TM PHARMA A/S (DK) 2003-10-23 WO disclosed